145 related articles for article (PubMed ID: 34233845)
1. Androgen receptor, neovascularization and liver cancer metastasis.
Feng MW; Hanley KL; Feng GS
J Hepatol; 2021 Oct; 75(4):768-769. PubMed ID: 34233845
[No Abstract] [Full Text] [Related]
2. Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation.
Yang Z; Chen J; Xie H; Liu T; Chen Y; Ma Z; Pei X; Yang W; Li L
Cancer Lett; 2020 Mar; 473():118-129. PubMed ID: 31843555
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor in human endothelial cells.
Torres-Estay V; Carreño DV; San Francisco IF; Sotomayor P; Godoy AS; Smith GJ
J Endocrinol; 2015 Mar; 224(3):R131-7. PubMed ID: 25563353
[TBL] [Abstract][Full Text] [Related]
4. Tumoristatic effects of endostatin in prostate cancer is dependent on androgen receptor status.
Isayeva T; Moore LD; Chanda D; Chen D; Ponnazhagan S
Prostate; 2009 Jul; 69(10):1055-66. PubMed ID: 19301304
[TBL] [Abstract][Full Text] [Related]
5. Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer.
Schatzl G; Madersbacher S; Haitel A; Gsur A; Preyer M; Haidinger G; Gassner C; Ochsner M; Marberger M
J Urol; 2003 Apr; 169(4):1312-5. PubMed ID: 12629350
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling.
Bao S; Jin S; Wang C; Tu P; Hu K; Lu J
J Cell Mol Med; 2020 Dec; 24(23):14110-14120. PubMed ID: 33118329
[TBL] [Abstract][Full Text] [Related]
7. Measurement of androgen receptor expression in adult liver, fetal liver, and Hep-G2 cells by the polymerase chain reaction.
Stubbs AP; Engelman JL; Walker JI; Faik P; Murphy GM; Wilkinson ML
Gut; 1994 May; 35(5):683-6. PubMed ID: 8200566
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor variants: another twist in the plot.
Macoska JA
Oncotarget; 2017 Mar; 8(10):16100. PubMed ID: 28184022
[No Abstract] [Full Text] [Related]
9. Constitutively Active Androgen Receptor in Hepatocellular Carcinoma.
Montgomery EJ; Xing E; Campbell MJ; Li PK; Blachly JS; Tsung A; Coss CC
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430245
[TBL] [Abstract][Full Text] [Related]
10. Expression of androgen receptor mRNA in human hepatocellular carcinomas and hepatoma cell lines.
Nakagama H; Gunji T; Ohnishi S; Kaneko T; Ishikawa T; Makino R; Hayashi K; Shiga J; Takaku F; Imawari M
Hepatology; 1991 Jul; 14(1):99-102. PubMed ID: 1648543
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR.
You B; Sun Y; Luo J; Wang K; Liu Q; Fang R; Liu B; Chou F; Wang R; Meng J; Huang CP; Yeh S; Chang C; Xu W
Oncogene; 2021 Mar; 40(9):1674-1689. PubMed ID: 33510354
[TBL] [Abstract][Full Text] [Related]
12. Gender disparity of hepatocellular carcinoma: role of hepatitis B virus X protein and androgen receptor.
Chiu YT; Ng IO
Hong Kong Med J; 2016 Jun; 22(3 Suppl 4):43-7. PubMed ID: 27390010
[No Abstract] [Full Text] [Related]
13. The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals.
Xu J; Lin H; Li G; Sun Y; Chen J; Shi L; Cai X; Chang C
EBioMedicine; 2016 Oct; 12():55-67. PubMed ID: 27688096
[TBL] [Abstract][Full Text] [Related]
14. Roles of the Androgen--Androgen Receptor System in Vascular Angiogenesis.
Yoshida S; Ikeda Y; Aihara K
J Atheroscler Thromb; 2016; 23(3):257-65. PubMed ID: 26522430
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer.
Naiki-Ito A; Naiki T; Kato H; Iida K; Etani T; Nagayasu Y; Suzuki S; Yamashita Y; Inaguma S; Onishi M; Tanaka Y; Yasui T; Takahashi S
Carcinogenesis; 2020 Aug; 41(8):1145-1157. PubMed ID: 31805186
[TBL] [Abstract][Full Text] [Related]
16. SIRNA-directed in vivo silencing of androgen receptor inhibits the growth of castration-resistant prostate carcinomas.
Compagno D; Merle C; Morin A; Gilbert C; Mathieu JR; Bozec A; Mauduit C; Benahmed M; Cabon F
PLoS One; 2007 Oct; 2(10):e1006. PubMed ID: 17925854
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cells enhance prostate cancer metastasis via IL-6→androgen receptor→TGF-β→MMP-9 signals.
Wang X; Lee SO; Xia S; Jiang Q; Luo J; Li L; Yeh S; Chang C
Mol Cancer Ther; 2013 Jun; 12(6):1026-37. PubMed ID: 23536722
[TBL] [Abstract][Full Text] [Related]
18. Sex-specific changes in the expression of ER-alpha and androgen receptor with increasing tumor grade in patients with hepatocellular carcinoma.
Berkel C; Cacan E
Hum Cell; 2022 May; 35(3):948-951. PubMed ID: 35349116
[No Abstract] [Full Text] [Related]
19. Cancer stem cell and mesenchymal cell cooperative actions in metastasis progression and hormone resistance in prostate cancer: Potential role of androgen and gonadotropin‑releasing hormone receptors (Review).
Contreras HR; López-Moncada F; Castellón EA
Int J Oncol; 2020 May; 56(5):1075-1082. PubMed ID: 32319606
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
